MedTrace Logo

Defibrillation Testing During Implantable Cardioverter Defibrillator (ICD) Replacement

NCT04206371 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 143

Last updated 2026-05-14

Study results available
· View outcomes & findings →

Summary

This study will evaluate safety and clinical outcomes of a systematic defibrillation threshold testing in patient with indication for defibrillator replacement.

Conditions

  • Implantable Cardioverter-Defibrillators

Interventions

DIAGNOSTIC_TEST

Defibrillator threshold testing

Under general or local anesthesia. Induction of Ventricular Fibrillation or R-wave synchronized shock

Sponsors & Collaborators

  • CMC Ambroise Paré

    lead OTHER

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-03
Primary Completion
2022-01-19
Completion
2023-06-27

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04206371 on ClinicalTrials.gov